Table 4.
Levels of resistance and resistance mutation scores among protease inhibitors, nucleoside reverse transcriptase inhibitors, and nonnucleoside reverse transcriptase inhibitors in all tests conducted among 18 treatment-naive patients, Mumbai, Maharashtra, India*